Circulation 129(5):587597 van Bommel EJ, Muskiet MH, van Baar MJ, Tonneijck L, Smits MM, Emanuel AL et al (2019) The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial
For a full list of possible side effects, and other important safety information, please reference the Mayo Clinics list of Semaglutide side effects
H., Chahdoura, H., Barros, L., Dias, M
Recent clinical studies showed that GSH levels in the brains of ALS patients were decreased compared to those of age-matched healthy volunteers [181], and the decrease of GSH levels was more prominent in the motor cortex than in the white matter of ALS patients [182]